NKTR — Nektar Therapeutics stock price, charts and financials

QT61Nektar Therapeutics

Nektar Therapeutics (NASDAQ: NKTR) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
72.76
+2.17+3.07%
OverviewShort InterestFilings
NKTRQT61Nektar Therapeutics·NASDAQ
72.76+3.07%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Jul 31, 2026SC 13GBeneficial ownership statement (passive)
Jul 29, 2026SC 13GBeneficial ownership statement (passive)
Jul 24, 20264Statement of changes in beneficial ownership
Jul 24, 20264Statement of changes in beneficial ownership
Jul 02, 20264Statement of changes in beneficial ownership
Jun 18, 20264Statement of changes in beneficial ownership
Jun 17, 20264Statement of changes in beneficial ownership
Jun 05, 20268-KCurrent report
May 26, 20263Initial statement of beneficial ownership
May 21, 20264Statement of changes in beneficial ownership
May 21, 20264Statement of changes in beneficial ownership
May 15, 2026SC 13G/ABeneficial ownership statement (passive, amended)
May 08, 2026424B5Prospectus
May 08, 202610-QQuarterly report
May 08, 20268-KCurrent report
May 07, 20268-KCurrent report
May 06, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Apr 24, 2026DEFA14AAdditional proxy soliciting materials
Apr 24, 2026DEF 14ADefinitive proxy statement
Apr 24, 2026ARSAnnual report to shareholders
Apr 23, 2026424B5Prospectus
Apr 23, 20268-KCurrent report
Apr 20, 20268-KCurrent report
Apr 20, 2026424B5Prospectus
Apr 20, 20268-KCurrent report
#1 / 25 of 330
Page
▼
/ 14